Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

BioLineRx (BLRX) Revenue: 2012-2024

Historic Revenue for BioLineRx (BLRX) over the last 13 years, with Dec 2024 value amounting to $28.9 million.

  • BioLineRx's Revenue fell 94.36% to $304,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $17.3 million, marking a year-over-year increase of 41.95%. This contributed to the annual value of $28.9 million for FY2024, which is 502.92% up from last year.
  • According to the latest figures from FY2024, BioLineRx's Revenue is $28.9 million, which was up 502.92% from $4.8 million recorded in FY2023.
  • BioLineRx's 5-year Revenue high stood at $28.9 million for FY2024, and its period low was $1.0 million during FY2021.
  • Its 3-year average for Revenue is $12.0 million, with a median of $4.8 million in 2023.
  • Per our database at Business Quant, BioLineRx's Revenue tumbled by 38.24% in 2021 and then soared by 502.92% in 2024.
  • BioLineRx's Revenue (Yearly) stood at $1.6 million in 2020, then plummeted by 38.24% to $1.0 million in 2021, then spiked by 114.51% to $2.2 million in 2022, then soared by 122.43% to $4.8 million in 2023, then skyrocketed by 502.92% to $28.9 million in 2024.